Journal
NUTRIENTS
Volume 15, Issue 18, Pages -Publisher
MDPI
DOI: 10.3390/nu15183885
Keywords
COVID-19; SARS-CoV-2; natural dietary polyphenols; curcumin; resveratrol; gossypol; nanotechnology; lead optimization; combination therapies; broad-spectrum activities
Categories
Ask authors/readers for more resources
The COVID-19 pandemic has led to collaborative efforts in academia and the industry to develop therapies and vaccines targeting SARS-CoV-2. Natural products, particularly dietary polyphenols, have gained renewed interest as an additional therapeutic strategy. In vitro and in vivo studies have shown the potential of polyphenols such as curcumin, resveratrol, and gossypol as inhibitors against SARS-CoV-2 and its variants. Strategies such as nanotechnology, lead optimization, combination therapies, and broad-spectrum activities have also been highlighted to support effective drug development for long-term pandemic management and control.
The COVID-19 pandemic has stimulated collaborative drug discovery efforts in academia and the industry with the aim of developing therapies and vaccines that target SARS-CoV-2. Several novel therapies have been approved and deployed in the last three years. However, their clinical application has revealed limitations due to the rapid emergence of viral variants. Therefore, the development of next-generation SARS-CoV-2 therapeutic agents with a high potency and safety profile remains a high priority for global health. Increasing awareness of the back to nature approach for improving human health has prompted renewed interest in natural products, especially dietary polyphenols, as an additional therapeutic strategy to treat SARS-CoV-2 patients, owing to its good safety profile, exceptional nutritional value, health-promoting benefits (including potential antiviral properties), affordability, and availability. Herein, we describe the biological properties and pleiotropic molecular mechanisms of dietary polyphenols curcumin, resveratrol, and gossypol as inhibitors against SARS-CoV-2 and its variants as observed in in vitro and in vivo studies. Based on the advantages and disadvantages of dietary polyphenols and to obtain maximal benefits, several strategies such as nanotechnology (e.g., curcumin-incorporated nanofibrous membranes with antibacterial-antiviral ability), lead optimization (e.g., a methylated analog of curcumin), combination therapies (e.g., a specific combination of plant extracts and micronutrients), and broad-spectrum activities (e.g., gossypol broadly inhibits coronaviruses) have also been emphasized as positive factors in the facilitation of anti-SARS-CoV-2 drug development to support effective long-term pandemic management and control.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available